NCI Events
Featured Event

DCP Early Career Scientist Spotlight Research Seminar Series
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) has created the DCP Early Career Scientist Spotlight Research Seminar Series to highlight nominated early career scientists who are advancing research within the areas supported by DCP. The overall goal of this ongoing seminar series is to increase visibility and provide recognition to these DCP Early Career Scientists.
Need an Event Site?

Upcoming Events
(Displaying 8 out of 8 results)July 2025

Cancer AI Conversations
“Cancer AI Conversations” are bimonthly, 1-hour virtual events featuring timely topics related to the application of artificial intelligence in cancer research. Each event features short talks from 2-4 subject matter experts offering diverse perspectives on the session topic. These talks will be followed by a moderated panel discussion.
August 2025

NCORP Annual Meeting
The National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Annual Meeting will be an in-person meeting, with a non-interactive virtual option. NCORP is an NCI-supported network that brings cancer treatment, prevention, control, and cancer care delivery research (CCDR) trials to people in their communities. The goal of the 2025 NCORP Annual Meeting is to bring together NCORP principal investigators, administrators, research staff, and extramural and NCI stakeholders who contribute to the overall goal of providing access to cancer research studies in the community setting. The meeting will provide a forum for the exchange of information about the implementation, challenges, and successes of this community-based research network. The meeting will include interactive breakout sessions to address a broad scope of NCORP-related topics.

Using the NCI Method for Measurement Error Adjustment
Using the NCI Method for Measurement Error Adjustment is a 5-day workshop being held at the NCI Shady Grove Campus in Rockville, MD. In current practice, assessments of modifiable risk factors for cancer, like physical activity and nutrition, are subject to substantial amounts of measurement error for which simple corrections are infeasible or impossible. Ignoring these errors can lead to spurious results and incorrect conclusions about associations with cancer outcomes.
September 2025

Fall 2025 NCI Early Drug Development
The NCI CTEP Early Drug Development Meeting is held annually to enhance communication between NCI and the network of ETCTN investigators that conduct CTEP-sponsored early phase clinical trials. The meeting is open to academic, government, and pharmaceutical clinical investigators and related health care personnel (e.g., nurses, statisticians, translational scientist, etc.) involved in CTEP funded oncology early drug development. The focus of the meeting is on prioritizing investigational agent selection and targeting, novel trial designs, and development and implementation of translational studies, as well as on new therapeutic and imaging modalities. The data presented at the meeting is considered a private communication, and the information should not be disseminated for public use.

Transformative Microsystems for Cancer Diagnosis, Treatment Monitoring, and Clinical Integration
This workshop will bring together scientists, clinicians, engineers, patients, survivors, and advocates to explore cutting-edge microsystem technologies that are transforming cancer diagnostics, treatment monitoring, and disease management.

Childhood Cancer: NCI Office of Data Sharing (ODS) Inaugural Data Jamboree
Come and join us at the NCI's Office of Data Sharing (ODS) on September 29-30. The overall goal of this 1.5-day in-person event is to increase the visibility of a variety of childhood cancer datasets, promote interdisciplinary collaborations, and accelerate scientific innovation through enhanced data sharing and use, This ODS inaugural event will focus on solving specific problems in childhood cancer.

NCI's Office of Data Sharing Annual Symposium
Sept. 30th - Oct. 1st. A foundational shift to a culture of broad data sharing and collaborative science holds immense promise for more rapid advances in cancer research. NCI’s Office of Data Sharing will bring together experts and stakeholders including scientists, clinicians, policymakers, patients, advocates and trainees across government, academia and industry to learn from one another and explore ways to maximize the benefits of these efforts.

CPTAC Scientific Symposium Public
The National Cancer Institute’s Office of Cancer Clinical Proteomics Research (OCCPR) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) are pleased to announce the 2025 CPTAC Scientific Symposium. Join us on September 30, 2025 to learn about the most current advances in the field of cancer proteogenomics and cancer research by our CPTAC investigators. While this meeting is in-person for CPTAC consortium and NIH participants, only virtual option is available for public attendees.